Versiti Blood Research Institute, Milwaukee, WI.
HealthChart LLC, Memphis, TN.
J Immunol. 2023 May 1;210(9):1222-1235. doi: 10.4049/jimmunol.2200639.
The caspase recruitment domain family member (CARD)11-Bcl10-Malt1 signalosome controls TGF-β-activated kinase 1 (TAK1) activation and regulates BCR-induced NF-κB activation. In this study, we discovered that CARD19 interacted with TAK1 and inhibited TAB2-mediated TAK1 ubiquitination and activation. Although CARD19 deficiency in mice did not affect B cell development, it enhanced clonal deletion, receptor editing, and anergy of self-reactive B cells, and it reduced autoantibody production. Mechanistically, CARD19 deficiency increased BCR/TAK1-mediated NF-κB activation, leading to increased expression of transcription factors Egr2/3, as well as the E3 ubiquitin ligases c-Cbl/Cbl-b, which are known inducers of B cell tolerance in self-reactive B cells. RNA sequencing analysis revealed that although CARD19 deficiency did not affect the overall Ag-induced gene expression in naive B cells, it suppressed BCR signaling and increased hyporesponsiveness of self-reactive B cells. As a result, CARD19 deficiency prevented Bm12-induced experimental systemic lupus erythematosus. In summary, CARD19 negatively regulates BCR/TAK1-induced NF-κB activation and its deficiency increases Egr2/3 and c-Cbl/Cbl-b expression in self-reactive B cells, thereby enhancing B cell tolerance.
衔接蛋白(CARD)11-B 细胞淋巴瘤 10(Bcl10)-黏膜相关淋巴组织 1(Malt1)信号体控制转化生长因子-β 激活激酶 1(TAK1)的激活,并调节 B 细胞受体(BCR)诱导的核因子-κB(NF-κB)的激活。在这项研究中,我们发现衔接蛋白 19(CARD19)与 TAK1 相互作用,并抑制 TAB2 介导的 TAK1 泛素化和激活。虽然 CARD19 缺失的小鼠并不影响 B 细胞的发育,但它增强了自身反应性 B 细胞的克隆删除、受体编辑和无能,并且减少了自身抗体的产生。在机制上,CARD19 的缺失增加了 BCR/TAK1 介导的 NF-κB 的激活,导致转录因子 Egr2/3 的表达增加,以及 E3 泛素连接酶 c-Cbl/Cbl-b 的表达增加,c-Cbl/Cbl-b 是自身反应性 B 细胞中诱导 B 细胞耐受的已知因子。RNA 测序分析显示,尽管 CARD19 的缺失并不影响幼稚 B 细胞中整体抗原诱导的基因表达,但它抑制了 BCR 信号,并增加了自身反应性 B 细胞的低反应性。结果,CARD19 的缺失阻止了 Bm12 诱导的实验性系统性红斑狼疮。总之,CARD19 负调控 BCR/TAK1 诱导的 NF-κB 的激活,其缺失增加了自身反应性 B 细胞中 Egr2/3 和 c-Cbl/Cbl-b 的表达,从而增强了 B 细胞的耐受性。